Literature DB >> 11337030

Death the Fas way: regulation and pathophysiology of CD95 and its ligand.

K Sharma1, R X Wang, L Y Zhang, D L Yin, X Y Luo, J C Solomon, R F Jiang, K Markos, W Davidson, D W Scott, Y F Shi.   

Abstract

Apoptotic cell death mediated by the members of the tumor necrosis factor receptor family is an essential process involved in the regulation of cellular homeostasis during development, differentiation, and pathophysiological conditions. Among the cell death receptors comprising the tumor necrosis factor receptor superfamily, CD95/APO-1 (Fas) is the best characterized. The specific interaction of Fas with its cognate ligand, Fas ligand (FasL), elicits the activation of a death-inducing caspase (cysteine aspartic acid proteases) cascade, occurring in a transcription-independent manner. Caspase activation executes the apoptosis process by cleaving various intracellular substrates, leading to genomic DNA fragmentation, cell membrane blebbing, and the exposure of phagocytosis signaling molecules on the cell surface. Recent studies have shown that the Fas/FasL pathway plays an important role in regulating the life and death of the immune system through activation-induced cell death. In addition, these molecules have been implicated in aging, human immunodeficiency virus infection, drug abuse, stress, and cancer development. In this review, we will focus on the mechanisms that regulate Fas and FasL expression, and how their deregulation leads to diseases.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11337030     DOI: 10.1016/s0163-7258(00)00096-6

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  37 in total

Review 1.  Mitochondria-centric activation induced cell death of cytolytic T lymphocytes and its implications for cancer immunotherapy.

Authors:  Arvind Chhabra
Journal:  Vaccine       Date:  2010-05-06       Impact factor: 3.641

2.  Genetic polymorphisms of Fas (CD95) and Fas ligand (CD178) influence the rise in CD4+ T cell count after antiretroviral therapy in drug-naïve HIV-positive patients.

Authors:  Milena Nasi; Marcello Pinti; Roberto Bugarini; Leonarda Troiano; Enrico Lugli; Cristian Bellodi; Cristina Mussini; Vanni Borghi; Tommaso Trenti; Fiorella Balli; Roberto Esposito; Andrea Cossarizza
Journal:  Immunogenetics       Date:  2005-10-18       Impact factor: 2.846

3.  Clinical relevance of Fas expression in oesophageal squamous cell carcinoma.

Authors:  K W Chan; P Y Lee; A K Y Lam; S Law; J Wong; G Srivastava
Journal:  J Clin Pathol       Date:  2006-01       Impact factor: 3.411

4.  Update on the genetics characterization of vitiligo.

Authors:  Hani A Al-Shobaili
Journal:  Int J Health Sci (Qassim)       Date:  2011-07

5.  Fas-disabling small exocyclic peptide mimetics limit apoptosis by an unexpected mechanism.

Authors:  Akihiro Hasegawa; Xin Cheng; Kiichi Kajino; Alan Berezov; Kaoru Murata; Toshinori Nakayama; Hideo Yagita; Ramachandran Murali; Mark I Greene
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-14       Impact factor: 11.205

6.  The triterpenoid pristimerin induces U87 glioma cell apoptosis through reactive oxygen species-mediated mitochondrial dysfunction.

Authors:  Yan-Yan Yan; Jian-Ping Bai; Yong Xie; Jie-Zhong Yu; Cun-Gen Ma
Journal:  Oncol Lett       Date:  2012-10-22       Impact factor: 2.967

7.  Gene expressions in Jurkat cells poisoned by a sulphur mustard vesicant and the induction of apoptosis.

Authors:  Peng Zhang; Patrick Ng; Diana Caridha; Richard A Leach; Ludmila V Asher; Mark J Novak; William J Smith; Steven L Zeichner; Peter K Chiang
Journal:  Br J Pharmacol       Date:  2002-09       Impact factor: 8.739

8.  Role of PPAR-delta in the development of zymosan-induced multiple organ failure: an experiment mice study.

Authors:  Maria Galuppo; Rosanna Di Paola; Emanuela Mazzon; Tiziana Genovese; Concetta Crisafulli; Irene Paterniti; Elisabetta Cuzzocrea; Placido Bramanti; Amar Kapoor; Christoph Thiemermann; Salvatore Cuzzocrea
Journal:  J Inflamm (Lond)       Date:  2010-02-18       Impact factor: 4.981

9.  Serum markers of apoptosis decrease with age and cancer stage.

Authors:  Nilay Kavathia; Alka Jain; Jeremy Walston; Brock A Beamer; Neal S Fedarko
Journal:  Aging (Albany NY)       Date:  2009-07-14       Impact factor: 5.682

10.  The Fas system confers protection against alveolar disruption in hyperoxia-exposed newborn mice.

Authors:  Quanfu Mao; Sravanthi Gundavarapu; Chintan Patel; Amy Tsai; Francois I Luks; Monique E De Paepe
Journal:  Am J Respir Cell Mol Biol       Date:  2008-06-27       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.